Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism; School of Medicine, Johns Hopkins University, Baltimore, Maryland 21205, USA.
Welch Prevention Center for Prevention, Epidemiology and Clinical Research; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA; email:
Annu Rev Public Health. 2021 Apr 1;42:59-77. doi: 10.1146/annurev-publhealth-090419-102644. Epub 2021 Dec 23.
Prediabetes is an intermediate stage between normal glycemia and diabetes and is highly prevalent, especially in older age groups and obese individuals. Five different definitions of prediabetes are used in current practice, which are based on different cut points of HbA, fasting glucose, and 2-h glucose. A major challenge for the field is a lack of guidance on when one definition might be preferred over another. Risks of major complications in persons with prediabetes, including diabetes, cardiovascular disease, kidney disease, and death, also vary depending on the prediabetes definition used. Randomized clinical trials have demonstrated that lifestyle and pharmacologic interventions can be cost-effective, prevent diabetes, and improve cardiovascular risk factors in adults with prediabetes. However, the practical implementation of lifestyle modification or the use of metformin for treating prediabetes is inadequate and complicated by a lack of agreement on how to define the condition. Establishing consensus definitions for prediabetes should be a priority and will help inform expansion of insurance coverage for lifestyle modification and improve current screening and diagnostic practices.
糖尿病前期是血糖正常和糖尿病之间的中间阶段,患病率很高,尤其是在老年人群体和肥胖人群中。目前的临床实践中使用了五种不同的糖尿病前期定义,这些定义基于 HbA、空腹血糖和 2 小时血糖的不同切点。该领域的一个主要挑战是缺乏关于何时优先选择一种定义而不是另一种定义的指导。糖尿病前期患者(包括糖尿病、心血管疾病、肾脏疾病和死亡)的主要并发症风险也因所使用的糖尿病前期定义而异。随机临床试验表明,生活方式和药物干预措施可以具有成本效益,可以预防糖尿病,并改善糖尿病前期成年人的心血管风险因素。然而,生活方式改变或二甲双胍治疗糖尿病前期的实际实施情况并不理想,并且由于缺乏关于如何定义该病症的共识而变得复杂。为糖尿病前期建立共识定义应该是当务之急,这将有助于为生活方式改变扩大保险范围,并改善当前的筛查和诊断实践。